Atrophy and intestinal metaplasia one year after-cure of H. pylori Infection: A prospective, randomized study

Gastroenterology

Volumn 119, Issue 1, 2000, Pages 7-14

  Sung, Joseph J Y ^a   Lin, San Rin ^b   Ching, Jessica Y L ^a   Zhou, Li Ya ^b   To, Kar F ^a   Wang, Ren Ten ^b   Leung, Wai K ^a   Ng, Enders K W ^a   Lau, James Y W ^a   Lee, Yuk T ^a   Yeung, Chung K ^a   Chao, William ^a   Chung, S C Sydney ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CHRONIC GASTRITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH CANCER;

EID: 0034235499     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2000.8550     Document Type: Article

References (20)

1. Goldstone AR, Quirk PH, Dixon MF. Helicobacter pylori infection and gastric cancer. J Pathol 1996;179:129-137.
2. Mitchell HM, Li YY, Hu PJ, et al. Epidemiology of H. pylori in southern China: Identification of early childhood as the critical period for acquisition. J Infect Dis 1992;166:149-153.
3. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995;19:S37-S43.
4. Genta RM, Lew GM, Graham DY. Changes in the gastric mucosa following eradication of H. pylori. Mod Pathol 1993;6:281-289.
5. Haruma K, Mihara M, Kamada T, et al. Eradication of Helicobacter pylori reverses intestinal metaplasia in patients with severe atrophic gastritis (abstr). Gastroenterology 1997;112:A142.
6. Griffiths AE, Thursz MR, Walker MM. Do intestinal metaplasia and glandular atrophy reverse after H. pylori eradication? Gut 1997;41: A48-A49.
7. Ierardi E, Balzano I, Traversa A, et al. Lack of reversibility of epithelial proliferative changes after H. pylori eradication in areas of intestinal metaplasia (abstr). Gut 1996;39(suppl 2):A18.
8. Forbes GM, Warren JR, Glaser ME, Cullen DJE, Marshall BJ, Collins BJ. Long-term follow-up of gastric histology after H. pylori eradication. J Gastroenterol Hepatol 1996;11:670-673.
9. Van Der Hulst RWM, Van Der Ende A, Dekker FW, Ten Kate FJW, Weel JFL, Keller JJ, Kruizinga SP, Dankert J, Tytgat GNJ. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: A prospective 1-year follow-up study. Gastroenterology 1997;113:25-30.
10. Dixon MF, Genta RM, Yardley JH, Correa P, and the Participants in the International Workshop on the Histopathology of Gastritis, Houston 1994. Classification and grading of gastritis; the updated Sydney system. Am J Surg Pathol 1996;20:1161-1181.
11. Fleiss JL. Comparing the marginal totals of square contingency tables. Br J Math Statist Psychol 1971;24:117-123.
12. Van Der Hulst RWM, Rauws EAJ, Koycu B, Tannemaat MR, Tyssen JGP, Tytgat GNJ, Ten Date FJW. The influence of cure of H. pylori infection on the long term sequelae of gastritis: A prospective long term follow up study (abstr). Gut 1997;41(suppl 1):A54.
13. Uemura M, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, Sasaki N, Haruma K, Sumii K, Kajiyama G. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997;6:639-642.
14. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: Importance of the cagA status. J Natl Cancer Inst 1995;87:1777-1780.
15. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk of gastric cancer in people with cagA positive or cagA negative Helicobacter pylori infection. Gut 1997;40:297-301.
16. Perez-Perez GJ, Bhat N, Gaensbauer J, Fraser A, Taylor DN, Kuipers EJ, Zhang L, You WC, Blaser MJ. Int J Cancer 1997;72:453-456.
17. Mitchell HM, Hazell SL, Li YY, Hu PJ. Serological response to specific Helicobacter pylori antigens: Antibody against cagA antigen is not predictive of gastric cancer in a developing country. Am J Gastroenterol 1996;91:1785-1788.
18. Blaser MJ, Chyou PH, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 1995;55:562-565.
19. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169-1179.
20. Parsonnet J, Harris RA, Hack HM, Owens DK. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: A mandate for clinical trial. Lancet 1996;348:150-154.